Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines01:30

Cancer Vaccines

897
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
897
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radioactive ion beam range adaptation in mouse tumors using in-beam PET.

Communications medicine·2026
Same author

Letter to the Editor: Modern Management of Newly Diagnosed Vulvovaginal Melanoma: Is There a Role for Carbon Ion Radiotherapy? A Perspective From the Particle Therapy Co-Operative Group (PTCOG) Gynecological Subcommittee.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Research through Evaluation for Large Language Model in Patient-Clinician Communications.

Research square·2026
Same author

Morpho-anatomical and biochemical plasticity of chia (Salvia hispanica L.) microgreens following heavy-ion seed irradiation.

Plant physiology and biochemistry : PPB·2026
Same author

The future is not always uniform: rethinking radiotherapy through spatial fractionation.

Nature reviews. Clinical oncology·2026
Same author

Three-Discipline Collaborative Radiation Therapy (3DCRT) debate: Medical physics should focus less on geometric precision and more on biological outcomes.

Journal of applied clinical medical physics·2026

Related Experiment Video

Updated: Jan 3, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments.

Alexander Helm1, Daniel K Ebner2,3, Walter Tinganelli1

  • 1Trento Institute for Fundamental Physics and Applications-National Institute for Nuclear Physics, Trento, Italy.

International Journal of Particle Therapy
|November 28, 2019
PubMed
Summary

Heavy ion radiation combined with immunotherapy shows potential for treating metastatic cancer. This approach may offer unique benefits over conventional photon radiation for systemic disease response.

Keywords:
abscopal effectcombination immunotherapy-radiotherapyheavy-ion radiotherapyradiation-induced immunogenic cell death

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.1K

Related Experiment Videos

Last Updated: Jan 3, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.1K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Immunotherapy

Background:

  • Combining radiation therapy with immunotherapy has shown promise in reducing metastatic cancer.
  • Current research predominantly uses photon irradiation, overlooking particle therapy's potential.

Purpose of the Study:

  • To review recent advancements in heavy-ion combination therapy for cancer.
  • To explore the potential of heavy ions, beyond photons, in enhancing systemic disease response.

Main Methods:

  • Review of recent clinical trials and case reports.
  • Analysis of evidence focusing on heavy-ion therapy in combination with immunotherapy.
  • Comparison of heavy-ion particle therapy with conventional photon irradiation.

Main Results:

  • Combination of radiation and immunotherapy can lead to complete elimination of metastatic disease.
  • Heavy-ion therapy offers distinct biological effects and dose-distribution advantages.
  • The potential of heavy-ion combination therapy for systemic response remains largely unexplored.

Conclusions:

  • Heavy-ion combination therapy represents a promising, yet under-explored, avenue for cancer treatment.
  • Further research is warranted to elucidate the full potential of heavy ions in cancer immunotherapy.